COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #201 of 237
12/4 Late treatment study
Peng et al., Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfaa288 (Peer Reviewed)
Early versus late acute kidney injury among patients with COVID-19—a multicenter study from Wuhan, China
Source   PDF   Share   Tweet
Retrospective 4020 hospitalized patients in China showing non-statistically significant lower risk of acute kidney injury with HCQ.

Peng et al., 12/4/2020, retrospective, China, Asia, peer-reviewed, 21 authors.
risk of disease progression, 10.8% lower, RR 0.89, p = 0.63, treatment 29 of 453 (6.4%), control 256 of 3567 (7.2%), CQ/HCQ risk of AKI.
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.